Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction Therapy
Clinical trial NCT03435848 · COMPLETED
Trial details
- NCT number
- NCT03435848
- Sponsor
- BioSight Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-14
- Primary completion
- 2023-03-16
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.